Comparison of cardiovascular event predictability between the 2009 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations in a Korean chronic kidney disease cohort: the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease
Open Access
- 30 November 2023
- journal article
- research article
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 42 (6) , 700-711
Abstract
Background: The 2009 Chronic Kidney Disease Epidemiology Collaboration creatinine-based estimated glomerular filtration rate (eGFRcr) equation contains a race component that is not based on biology and may cause a bias in results. Therefore, the 2021 eGFRcr and creatinine-cystatin C–based eGFR (eGFRcr-cysC) equations were developed with no consideration of race. This study compared the cardiovascular event (CVE) and all-cause mortality and CVE combined predictability among the three eGFR equations in Korean chronic kidney disease (CKD) patients. Methods: This study included 2,207 patients from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease. Receiver operating characteristic (ROC) and net reclassification improvement (NRI) index were used to compare the predictability of the study outcomes according to the 2009 eGFRcr, 2021 eGFRcr, and 2021 eGFRcr-cysC equations. Results: The overall prevalence of CVE and all-cause mortality were 9% and 7%, respectively. There was no difference in area under the curve of ROC for CVE and mortality and CVE combined among all three equations. Compared to the 2009 eGFRcr, both the 2021 eGFRcr (NRI, 0.013; 95% confidence interval [CI], – 0.002 to 0.028) and the eGFRcr-cysC (NRI, –0.001; 95% CI, –0.031 to 0.029) equations did not show improved CVE predictability. Similar findings were observed for mortality and CVE combined predictability with both the 2021 eGFRcr (NRI, –0.019; 95% CI, –0.039–0.000) and the eGFRcr-cysC (NRI, –0.002; 95% CI, –0.023 to 0.018). Conclusion: The 2009 eGFRcr equation was not inferior to either the 2021 eGFRcr or eGFRcr-cysC equation in predicting CVE and the composite of mortality and CVE in Korean CKD patients.Keywords
Funding Information
- Korea Disease Control and Prevention Agency (2011E3300300, 2012E3301100, 2013E3301600, 2013E3301601, 2013E3301602, 2016E3300200, 2016E33 00201, 2016E3300202, 2019E320100, 2019E320101, 2019E320102, 2022-11-007)
- National Research Foundation of Korea (2017M3A9E4044649)
This publication has 25 references indexed in Scilit:
- KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methodsBMC Nephrology, 2014
- Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS StudyInternational Journal of Hypertension, 2013
- Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort studyBMC Nephrology, 2011
- Estimating glomerular filtration rate in Asian subjects: where do we stand?Kidney International, 2011
- Recent progress in the treatment of vascular calcificationKidney International, 2010
- First certified reference material for cystatin C in human serum ERM-DA471/IFCCClinical Chemistry and Laboratory Medicine (CCLM), 2010
- The Association of African Ancestry and Elevated Creatinine in the Coronary Artery Risk Development in Young Adults (CARDIA) StudyAmerican Journal of Nephrology, 2009
- Cardiovascular disease in patients with chronic kidney diseaseVascular Health and Risk Management, 2009
- Chronic Kidney Disease Prevalence Estimates among Racial/Ethnic GroupsClinical Journal of the American Society of Nephrology, 2008
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999